The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.60/5, ranking #4 among 61 OTC devices tested in our lab. At $899, this behind-the-ear rechargeable device delivers strong performance that has earned it consecutive Expert's Choice Awards in 2023 and 2024.
In our testing, the B2 Plus excels in speech clarity and own-voice comfort. Speech in quiet scores a strong 4.3/5, measuring 1.65 points above the category average. Own-voice comfort is excellent at 4.8/5, a full 2.30 points above average—a notable achievement that makes the device comfortable for extended wear. Speech in noise scores 2.0/5, which is 0.80 points above the category average but mixed in absolute terms, meaning challenging listening environments may still require effort.
The device shows some limitations in feedback handling, scoring 2.8/5 compared to the category average of 4.53/5. Music streaming performance is mixed at 2.6/5, though still 0.73 points above the OTC average. Within its price range, competitors like the Sony CRE-E10 (5.00/5) and Elehear Beyond Pro (4.78/5) score higher, though the B2 Plus remains a top-5% performer in the broader OTC category.
The Lexie B2 Plus is well-suited for users who prioritize comfortable everyday speech clarity over music streaming or challenging noise environments. Its strong out-of-box performance and rechargeable convenience make it a solid choice for those new to hearing aids.
